BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15948206)

  • 1. Calpain-dependent alpha-fodrin cleavage at the sarcolemma in muscle diseases.
    Takamure M; Murata KY; Tamada Y; Azuma M; Ueno S
    Muscle Nerve; 2005 Sep; 32(3):303-9. PubMed ID: 15948206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.
    Kuru S; Inukai A; Kato T; Liang Y; Kimura S; Sobue G
    Acta Neuropathol; 2003 Mar; 105(3):217-24. PubMed ID: 12557007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utrophin is a calpain substrate in muscle cells.
    Courdier-Fruh I; Briguet A
    Muscle Nerve; 2006 Jun; 33(6):753-9. PubMed ID: 16598790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspases rather than calpains mediate remodelling of the fodrin skeleton during human placental trophoblast fusion.
    Gauster M; Siwetz M; Orendi K; Moser G; Desoye G; Huppertz B
    Cell Death Differ; 2010 Feb; 17(2):336-45. PubMed ID: 19798107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K; Nakamura A; Hijikata T; Takeda S
    BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain 1-gamma filamin interaction in muscle cells: a possible in situ regulation by PKC-alpha.
    Raynaud F; Jond-Necand C; Marcilhac A; Fürst D; Benyamin Y
    Int J Biochem Cell Biol; 2006 Mar; 38(3):404-13. PubMed ID: 16297652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased dysferlin expression in Duchenne muscular dystrophy.
    Vontzalidis A; Terzis G; Manta P
    Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):15-22. PubMed ID: 24902367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
    Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
    BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice.
    Gailly P; De Backer F; Van Schoor M; Gillis JM
    J Physiol; 2007 Aug; 582(Pt 3):1261-75. PubMed ID: 17510188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction.
    Paepe BD; Creus KK; Weis J; Bleecker JL
    Neuromuscul Disord; 2012 Jan; 22(1):26-33. PubMed ID: 21855341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia-related apoptosis is regulated differently in fast- and slow-twitch muscles of the aging F344/N x BN rat model.
    Rice KM; Blough ER
    Mech Ageing Dev; 2006 Aug; 127(8):670-9. PubMed ID: 16678239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
    Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
    Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular distribution of proteolytic enzymes in the skeletal muscle of sarcoid myopathy.
    Kumamoto T; Yukishige K; Ito T; Nagao S; Mori T; Ueyama H; Tsumura H; Tsuda T
    Acta Neuropathol; 2002 Jul; 104(1):38-44. PubMed ID: 12070662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two populations of beta-spectrin in rat skeletal muscle.
    Porter GA; Scher MG; Resneck WG; Porter NC; Fowler VM; Bloch RJ
    Cell Motil Cytoskeleton; 1997; 37(1):7-19. PubMed ID: 9142435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
    Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
    Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative result in search for human alpha-dystrobrevin deficiency.
    Ishikawa H; Nonaka I; Nishino I
    Muscle Nerve; 2003 Sep; 28(3):387-8. PubMed ID: 12929204
    [No Abstract]   [Full Text] [Related]  

  • 18. Ca2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle.
    Murphy RM; Verburg E; Lamb GD
    J Physiol; 2006 Oct; 576(Pt 2):595-612. PubMed ID: 16857710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy.
    Chen YW; Nagaraju K; Bakay M; McIntyre O; Rawat R; Shi R; Hoffman EP
    Neurology; 2005 Sep; 65(6):826-34. PubMed ID: 16093456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of fodrin by m-calpain in fibroblasts adhering to fibrillar collagen I gel.
    Sato K; Hattori S; Irie S; Sorimachi H; Inomata M; Kawashima S
    J Biochem; 2004 Dec; 136(6):777-85. PubMed ID: 15671488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.